Fetal Tissue Funding

PUBLISHED: 7:49 PM 25 Sep 2018

Trump Administration Ends $15,900 Contract With Fetal Tissue Research Company

The team of 85 members of Congress signed a letter demanding funding for the horrendous practice to end.

The Department of Health and Human Services recently announced that it would no longer allow the Food and Drug Administration to obtain fetal remains from a research company using federal funding.

The entire concept of abortion is horrendous already, yet what is sometimes done with fetal remains following the murderous procedure is equally horrifying to those with any regard for life. While President Donald Trump is undeniably pro-life, a contract pertaining to fetal remains was finally just now cancelled following a group of Congressmen signing a letter to the Food and Drug Administration demanding that thousands of dollars no longer be provided to an organization affiliated with such body part harvesting.

The funding of nearly $16,000 was formerly agreed upon by the FDA and Advanced Bioscience Resources which provides fetal remains for scientific testing. However, upon the concerned pro-life politicians discovering that the research company was doing so, it took action and successfully ensured that it would not earn a penny more under the Trump administration, something that arguably should have been done months ago.

In July, the FDA, “which is under the Department of Health and Human Services,” signed a contract with the research company to obtain fetal remains, along with mice, for medical testing purposes.

However, said studies sometimes involved using aborted fetal tissue or other body parts, which pro-life legislators naturally found to be horrifying.

To this, a staggering 85 members of Congress signed a letter to the commissioner of the FDA, Scott Gottlieb, expressing their horrors in funding such a terrible type of research.

The letter, finalized on September 17, boldly explained that “The practice of conducting research using the body parts of children whose lives who have been violently ended by abortion is abhorrent” and that “unborn children are not commodities to be bought and sold.”

It further encouraged that any future research be conducted by any other means that does not use an unborn child’s remains.

Monday evening, HHS announced that the FDA must sever ties with the organization which it formerly partnered with to conduct studies.

Naturally, the recent letter and subsequent defunding efforts drew attention from a reported 48 pro-life groups, including the Susan B. Anthony List, which a spokesperson on behalf of expressed the horror that federal funding had been granted for such purposes, especially under a pro-life presidential administration.

However, there is undeniable controversy even on the right pertaining to the concept of using fetal remains in such a way.

Many argue that it is a necessary evil considering that fetal remains have been said to have successfully aided science in conducting medical testing, particularly in developing life-saving vaccines.

Those taking up such a school of thought have argued that studies using fetal remains can be considered pro-life given the positive effect they can have in creating advanced medicines.

While there they may be some truth to that, strict anti-abortion advocates will argue that that makes the practice no less horrendous considering the lack of respect being given to the bodies of unborn babies’ who were not even given a chance at life.

However, the recent FDA attempt to obtain fetal remains was not to immediately improve healthcare technology but to horrifically use such tissue to create “humanized mice with human immune systems” which could be used for medical research.

Sure, successful scientific developments have been achieved using fetal tissue, but it is arguably time for such a practice to end considering how far medicine has already come, the alternatives which may be used instead, and the degree to which fetal harvesting has been occurring.

Yet ethics aside, the legal element here remains given that “federal law prohibits the buying and selling of human fetal tissue for ‘valuable consideration.’” Devastatingly, that is what is occurring through organizations such as Advanced Bioscience Resources.

In 2016, both the House Select Investigative Panel on Infant Lives and the Senate Judiciary Committee carried out investigations, including into ABR.

It was then discovered that ABR had been collecting and providing fetal remains in a similar fashion to how abortion clinics such as Planned Parenthood harvest them: either per whole fetus or in individual body parts.

ABR disgustingly claimed that the remains of an intact fetus cost around $60, but if said unborn child is dismembered, then the body parts sold on a ‘per specimen’ basis, including the “brain, eyes, liver, thymus, and lungs,” can value a collective $325.

The letter to the FDA requested a response by October 1; however, HHS under the Trump administration already took action in discontinuing the funding, noting that it “was not sufficiently assured that the contract included the appropriate protections applicable to fetal tissue research or met all procurement requirements.”

This is a notable win for pro-life efforts considering that the FDA had apparently been advocating for Advanced Bioscience Resources, claiming it to be “the only company in the U.S. capable of supplying” the devastatingly once-developing human remains, continuing that “no other company or organization is capable of fulfilling the need.”

While there, unfortunately, may never be a stop to abortion itself, every bit of federal funding that restricts organizations that partake in the practice and fetal remain harvesting can be considered a win for pro-life advocates, and, most importantly, unborn babies.

Thankfully, there remain pro-life organizations and politicians willing to step in and fight for the right to life and the fate of the unborn children whose remains deserve to be treated with respect and not as a science experiment.